Healthtech VC funding rose 30.4% in Q1, reaching $3.5 billion across 185 deals. B2B AI tools and consumer-facing health platforms drove the funding resurgence with six deals over $100 million. Function Health, Hippocratic AI, Abridge, OpenEvidence, and Cera quickly scaled to unicorn status, reflecting surging demand for personalized health data and new opportunities in health-system AI integration. Exit activity also increased in the quarter with 33 VC-backed healthtech companies exiting—the highest total since Q2 2021. Rising PE interest in the vertical, particularly in tech-enabled B2B solutions, is driving much-needed exit liquidity for healthtech investors.
Read the full article: PitchBook’s Q1 2025 Healthtech VC Trends //
Source: https://pitchbook.com/news/reports/q1-2025-healthtech-vc-trends